Cvs stock forecast 2025 technical analysts cite a symmetrical

Technical analysts cite a symmetrical triangle formation, implying a possible upward breakout, lending a positive skew to the CVS stock forecast 2025 mid‑year projections. On an adjusted basis, the company reported a profit of $1.31 per share for the first quarter, below analysts' average estimate of $1.69. This article is not financial advice. See Quiver Quantitative's disclaimers for more information. CVS’s expansion in telehealth and specialty pharmacy lines could support its stock forecast 2025, with potential upside toward $98 if cost management remains on target and market sentiment improves.